(SKWD) Skyward Specialty Insurance - Overview
Sector: Financial Services | Industry: Insurance - Property & Casualty | Exchange: NASDAQ (USA) | Market Cap: 1.785m USD | Total Return: -24.8% in 12m
Industry Rotation: +11.5
Avg Turnover: 18.6M
EPS Trend: 96.7%
Qual. Beats: 6
Rev. Trend: 98.0%
Qual. Beats: 0
Warnings
Extended 3d Choppy
Tailwinds
No distinct edge detected
Skyward Specialty Insurance Group, Inc. (SKWD) is a Houston-based insurance holding company specializing in commercial property and casualty (P&C) solutions. The firm delivers a diverse portfolio of niche products, including professional liability, cyber, surety, and workers compensation, alongside specialty reinsurance for the agriculture and credit sectors. Formerly known as Houston International Insurance Group, the company rebranded in 2020 to reflect its focus on specialized underwriting.
Operating within the P&C sector, the company utilizes a specialty insurance model, which focuses on risks that standard insurers typically avoid due to complexity or unique requirements. This segment often allows for more flexible policy pricing and terms compared to the highly regulated admitted market. Evaluating the companys historical underwriting discipline on ValueRay can provide further insight into its long-term stability. Skyward Specialty serves a broad range of domestic clients through both primary insurance and reinsurance structures.
- Expansion into high-margin specialty lines drives gross written premium growth
- Underwriting discipline and low loss ratios enhance net income margins
- Rising interest rates increase investment income on fixed income portfolios
- Exposure to catastrophic weather events impacts commercial property loss reserves
- Competitive pricing in excess and surplus markets pressures organic revenue growth
| Net Income: 177.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.05 > 1.0 |
| NWC/Revenue: -25.65% < 20% (prev 119.4%; Δ -145.1% < -1%) |
| CFO/TA 0.07 > 3% & CFO 427.9m > Net Income 177.7m |
| Net Debt (-1.97b) to EBITDA (242.2m): -8.11 < 3 |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.9m) vs 12m ago 1.19% < -2% |
| Gross Margin: 31.03% > 18% (prev 0.28%; Δ 3.07k% > 0.5%) |
| Asset Turnover: 28.07% > 50% (prev 30.13%; Δ -2.06% > 0%) |
| Interest Coverage Ratio: 12.39 > 6 (EBITDA TTM 242.2m / Interest Expense TTM 13.8m) |
| A: -0.06 (Total Current Assets 3.28b - Total Current Liabilities 3.66b) / Total Assets 6.55b |
| B: 0.05 (Retained Earnings 316.9m / Total Assets 6.55b) |
| C: 0.03 (EBIT TTM 171.1m / Avg Total Assets 5.29b) |
| D: 0.06 (Book Value of Equity 311.2m / Total Liabilities 5.32b) |
| Altman-Z'' Score: 0.06 = B |
| DSRI: 0.51 (Receivables 830.5m/1.32b, Revenue 1.48b/1.21b) |
| GMI: 0.90 (GM 31.03% / 27.89%) |
| AQI: 0.96 (AQ_t 0.50 / AQ_t-1 0.52) |
| SGI: 1.22 (Revenue 1.48b / 1.21b) |
| TATA: -0.04 (NI 177.7m - CFO 427.9m) / TA 6.55b) |
| Beneish M-Score: -3.42 (Cap -4..+1) = AA |
Over the past week, the price has changed by +4.38%, over one month by +2.88%, over three months by +5.91% and over the past year by -24.76%.
- StrongBuy: 3
- Buy: 4
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 60.5 | 26.3% |
P/E Forward = 9.3458
P/S = 1.1415
P/B = 1.6964
P/EG = 0.7245
Revenue TTM = 1.48b USD
EBIT TTM = 171.1m USD
EBITDA TTM = 242.2m USD
Long Term Debt = 120.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 486.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.97b USD (recalculated: Debt 486.0m - CCE 2.45b)
Enterprise Value = 1.79b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 12.39 (Ebit TTM 171.1m / Interest Expense TTM 13.8m)
EV/FCF = 4.21x (Enterprise Value 1.79b / FCF TTM 424.3m)
FCF Yield = 23.77% (FCF TTM 424.3m / Enterprise Value 1.79b)
FCF Margin = 28.58% (FCF TTM 424.3m / Revenue TTM 1.48b)
Net Margin = 11.97% (Net Income TTM 177.7m / Revenue TTM 1.48b)
Gross Margin = 31.03% ((Revenue TTM 1.48b - Cost of Revenue TTM 1.02b) / Revenue TTM)
Gross Margin QoQ = 32.98% (prev 30.07%)
Tobins Q-Ratio = 0.27 (Enterprise Value 1.79b / Total Assets 6.55b)
Interest Expense / Debt = 1.59% (Interest Expense 7.72m / Debt 486.0m)
Taxrate = 19.89% (12.3m / 62.1m)
NOPAT = 137.1m (EBIT 171.1m * (1 - 19.89%))
Current Ratio = 0.90 (Total Current Assets 3.28b / Total Current Liabilities 3.66b)
Debt / Equity = 0.40 (Debt 486.0m / totalStockholderEquity, last quarter 1.22b)
Debt / EBITDA = -8.11 (Net Debt -1.97b / EBITDA 242.2m)
Debt / FCF = -4.63 (Net Debt -1.97b / FCF TTM 424.3m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.36% (Net Income 177.7m / Total Assets 6.55b)
RoE = 17.35% (Net Income TTM 177.7m / Total Stockholder Equity 1.02b)
RoCE = 14.95% (EBIT 171.1m / Capital Employed (Equity 1.02b + L.T.Debt 120.0m))
RoIC = 12.73% (NOPAT 137.1m / Invested Capital 1.08b)
WACC = 6.21% (E(1.79b)/V(2.27b) * Re(7.56%) + D(486.0m)/V(2.27b) * Rd(1.59%) * (1-Tc(0.20)))
Discount Rate = 7.56% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 83.55 | Cagr: 2.53%
[DCF] Terminal Value 87.67% ; FCFF base≈375.9m ; Y1≈463.8m ; Y5≈791.2m
[DCF] Fair Price = 576.1 (EV 21.39b - Net Debt -1.97b = Equity 23.36b / Shares 40.5m; r=6.21% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 96.68 | EPS CAGR: 46.30% | SUE: 1.96 | # QB: 6
Revenue Correlation: 98.01 | Revenue CAGR: 31.42% | SUE: -0.63 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.19 | Chg30d=-3.06% | Revisions=-33% | Analysts=9
EPS next Quarter (2026-09-30): EPS=1.23 | Chg30d=+0.76% | Revisions=+0% | Analysts=9
EPS current Year (2026-12-31): EPS=4.93 | Chg30d=+1.22% | Revisions=+56% | GrowthEPS=+23.2% | GrowthRev=+39.8%
EPS next Year (2027-12-31): EPS=5.47 | Chg30d=+0.20% | Revisions=+25% | GrowthEPS=+11.0% | GrowthRev=+4.1%
[Analyst] Revisions Ratio: +56%